← FDA DRUG APPROVALS

FDA ANDA · ANDA077811

NIMODIPINE

Sponsor: HERITAGE

APPLICATION
ANDA077811
TYPE
ANDA
ORIGINAL APPROVAL
2007-05-02
LATEST ACTION
2013-06-21
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

NIMODIPINEPrescription
NIMODIPINE 30MG · CAPSULE · ORAL

Approval history

2013-06-21Labeling · Supplement 1AP
2007-05-02OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →